ClinicalTrials.Veeva

Menu

The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Connective Tissue Disease
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01809574
225-12-MMC

Details and patient eligibility

About

We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age above 18 years old
  • ILD according to ATS/ERS guidelines
  • Signed inform consent

Exclusion criteria

  • Previous lung surgery
  • Other significant systemic disease

Trial contacts and locations

1

Loading...

Central trial contact

David Shitrit, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems